elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
Published 7 months ago • 45 plays • Length 0:43Download video MP4
Download video MP3
Similar videos
-
4:02
anti-müllerian hormone (amh): know the age of your ovary
-
16:29
hormonal control in males
-
1:21
dr. harmon - what is the difference between you and an allergist?
-
1:09
prof. dr. hürzeler about how an intelligent implant design limits infectious risk
-
1:31
contraceptive barrier: non-surgical, non-hormonal, reversible
-
2:37
telomere length as a prognostic parameter in cll
-
4:03
monarche 4-year: abemaciclib endocrine therapy for hr , her2-, node-positive, high-risk early bc
-
2:51
risk stratification of patients with hormone-receptor positive breast cancer
-
8:46
endocrine15b-ovary (part 2)
-
1:52
cara kimmet, rn, iredell neurospine
-
1:05
ecbv ch 10 adrenal right
-
15:38
echilibru hormonal alimetatie
-
1:37
how bcr signaling influences cell proliferation in cll
-
2:30
actreen hi-lite tiemann range
-
5:37
how hormone and receptor systems evolve | frederik nijhout
-
4:19
monarche results: abemaciclib plus endocrine therapy in high-risk early breast cancer
-
1:24:43
airr-c webinar: computational mining of immune receptor germline gene loci variation